IAC

ANDES study shows less expensive therapy to be a "safe and well-tolerated" option

International experts advocate for accurate, timely information, while minimizing discrimination

Demonstrators used their time at the convention center to endorse the "U = U" message

Trial in Brazil offers hope for "late-presenter HIV patients"

SIMPL'HIV and NAMSAL trial data support WHO backing of dolutegravir, expert says

Functional cures now seen in 5 patients

Incidence of gonorrhea, chlamydia, and syphilis more than halved

Promising results after an unusual treatment regimen, though questions remain

IAS past president recalls history, local HCPs debate pros and cons

Other chemotherapies fall behind in resource-limited setting

Researchers warn of stigma, confusion in new policy

Earlier intervention on 'manageable factors' for fatty liver disease may help in this population

Challenges IAC delegates to overcome politics of division

Simple frailty index predicted worse outcomes